Search Back New search Go to resultsDiseaseMain groupSupportive Therapy, ToxicityProtocol groupImmunodeficienciesDiseaseAntibody Deficiency, Secondary to Hematological Neoplasms / after Stem Cell TransplantationSubgroupICD10D80.9MeSHAcquired Immunodeficiency SyndromeIgG DeficiencySequenceRHUH(800/1600/2400)/SCIgG(10/20/30), Sec. Antibody Deficiency, hemat. Neoplasia, C1 (PID1722) -|- RHUH2400/SCIgG30, C2+ (PID1727)ChemotherapyChemo-substanceHuman immunoglobulin (SCIg)Recombinant human hyaluronidaseChemo-substanceHuman immunoglobulin (SCIg)Recombinant human hyaluronidaseChemo-substanceHuman immunoglobulin (SCIg)Recombinant human hyaluronidaseChemo-substanceHuman immunoglobulin (SCIg)Recombinant human hyaluronidaseNo. Substances2 RadiotherapySupportive therapySupportive substanceHuman immunoglobulin (IVIg)Human immunoglobulin (SCIg)Recombinant human hyaluronidaseSupportive substanceHuman immunoglobulin (IVIg)Human immunoglobulin (SCIg)Recombinant human hyaluronidaseSupportive substanceHuman immunoglobulin (IVIg)Human immunoglobulin (SCIg)Recombinant human hyaluronidaseSupportive substanceHuman immunoglobulin (IVIg)Human immunoglobulin (SCIg)Recombinant human hyaluronidaseNo. Substances12Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationTherapy phaseTherapy intentionsupportiveRisksAllergic ReactionHeadacheInfusion ReactionNauseaPainPyrexia only studiesPublicationAuthorAngelotti FChapel HDiseaseSekundäre Hypogammaglobulinämie bedingt durch eine lymphoproliferative ErkrankungSekundärer Immunglobulinmangel bei hämatologischen oder soliden NeoplasienOriginDepartment of Immunology, Oxford Radcliffe Hospital, The John Radcliffe CampusUniversity of Pisa and Azienda Ospedaliera Universitaria Pisana, Pisa, ItalyProtocols in Revision 3 protocols foundProtocols under revision.Intravenous immunoglobulin-G 250, secondary antibody deficiency, hematologic neoplasms, stem cell transplantation (PID832 V1.0)Recombinant Human Hyaluronidase (800/1600/2400) / Subcutaneous Immunoglobulin-G (10/20/30), secondary antibody deficiency, hematologic neoplasms, stem cell transplantation, cycle 1 (PID1722 V1.0)Recombinant Human Hyaluronidase 2400 / Subcutaneous Immunoglobulin-G 30, secondary antibody deficiency, hematologic neoplasms, stem cell transplantation, cycle 2+ (PID1727 V1.0)
